1921
Volume 85, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Third generation cephalosporins are commonly used in the treatment of leptospirosis. The efficacy of first generation cephalosporins has been less well-studied. Susceptibility testing of 13 strains (11 serovars) to cefazolin and cephalexin was conducted using broth microdilution. Median minimal inhibitory concentration (MIC) for cefazolin and cephalexin ranged from < 0.016 to 2 μg/mL (MIC = 0.5 μg/mL) and from 1 to 8 μg/mL (MIC = 8 μg/mL), respectively. Efficacy of cefazolin and cephalexin in an acute lethal hamster model of leptospirosis was studied. Survival rates for cefazolin were 80%, 100%, and 100%, and survival rates for cephalexin were 50%, 80%, and 100% (treated with 5, 25, and 50 mg/kg per day for 5 days, respectively). Each treatment group showed improved survival compared with no treatment ( < 0.01), and none of the therapies, regardless of dose, was statistically significantly different than doxycycline. These results support a potential role for first generation cephalosporins as alternative therapies for leptospirosis.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2011.11-0352
2011-11-01
2017-09-21
Loading full text...

Full text loading...

/deliver/fulltext/14761645/85/5/905.html?itemId=/content/journals/10.4269/ajtmh.2011.11-0352&mimeType=html&fmt=ahah

References

  1. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, Vinetz JM, , 2003. Leptospirosis: a zoonotic disease of global. Lancet Infect Dis 3: 757771.[Crossref]
  2. Meites E, Jay MT, Deresinski S, Shieh WJ, Zaki SR, Tompkins L, Smith DS, , 2004. Reemerging leptospirosis, California. Emerg Infect Dis 10: 406412.[Crossref]
  3. Tangkanakul W, Tharmaphornpil P, Plikaytis BD, Bragg S, Poonsuksombat D, Choomkasien P, Kingnate D, Ashford DA, , 2000. Risk factors associated with leptospirosis in northeastern Thailand. Am J Trop Med Hyg 63: 204208.
  4. Vijayachari P, Sugunan AP, Shriram AN, , 2008. Leptospirosis: an emerging global public health problem. J Biosci 33: 557569.[Crossref]
  5. Griffith ME, Hospenthal DR, Murray CK, , 2006. Antimicrobial therapy of leptospirosis. Curr Opin Infect Dis 19: 533537.[Crossref]
  6. World Health Organization, 2003. Human Leptospirosis: Guidance for Diagnosis, Surveillance and Control. Geneva, Switzerland: World Health Organization.
  7. Panaphut T, Domrongkitchaiporn S, Vibhagool A, Thinkamrop B, Susaengrat W, , 2003. Ceftriaxone compared with sodium penicillin G for treatment of severe leptospirosis. Clin Infect Dis 36: 15071513.[Crossref]
  8. Phimda K, Hoontrakul S, Suttinont C, Chareonwat S, Losuwanaluk K, Chueasuwanchai S, Chierakul W, Suwancharoen D, Silpasakorn S, Saisongkorh W, Peacock SJ, Day NP, Suputtamongkol Y, , 2007. Doxycycline versus azithromycin for treatment of leptospirosis and scrub typhus. Antimicrob Agents Chemother 51: 32593263.[Crossref]
  9. Suputtamongkol Y, Niwattayakul K, Suttinont C, Losuwanaluk K, Limpaiboon R, Chierakul W, Wuthiekanun V, Triengrim S, Chenchittikul M, White NJ, , 2004. An open, randomized controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis. Clin Infect Dis 39: 14171424.[Crossref]
  10. Yoshimori RN, Goldberg HS, Blenden DC, , 1965. Cephalothin in the treatment of experimental leptospirosis in hamsters. Antimicrob Agents Chemother 5: 450452.
  11. Alexander AD, Rule PL, , 1986. Penicillins, cephalosporins, and tetracyclines in treatment of hamsters with fatal leptospirosis. Antimicrob Agents Chemother 30: 835839.[Crossref]
  12. Murray CK, Hospenthal DR, , 2004. Broth microdilution susceptibility testing for Leptospira spp. Antimicrob Agents Chemother 48: 15481552.[Crossref]
  13. Murray CK, Hospenthal DR, , 2004. Determination of susceptibilities of 26 Leptospira sp. serovars to 24 antimicrobial agents by broth microdilution technique. Antimicrob Agents Chemother 48: 40024005.[Crossref]
  14. Ressner RA, Griffith ME, Beckius ML, Pimentel G, Miller RS, Mende K, Fraser SL, Galloway RL, Hospenthal DR, Murray CK, , 2008. Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira . Antimicrob Agents Chemother 52: 27502754.[Crossref]
  15. Griffith ME, Moon JE, Johnson EN, Clark KP, Hawley JS, Hospenthal DR, Murray CK, , 2007. Efficacy of fluoroquinolones against Leptospira interrogans in a hamster model. Antimicrob Agents Chemother 51: 26152617.[Crossref]
  16. Moon JE, Ellis MW, Griffith ME, Hawley JS, Rivard RG, McCall S, Hospenthal DR, Murray CK, , 2006. Efficacy of macrolides and telithromycin against leptospirosis in a hamster model. Antimicrob Agents Chemother 50: 19891992.[Crossref]
  17. Moon JE, Rivard RG, Griffith ME, Ressner RA, McCall S, Reitstetter RE, Hospenthal DR, Murray CK, , 2007. Effect of timing and duration of azithromycin therapy of leptospirosis in a hamster model. J Antimicrob Chemother 59: 148151.[Crossref]
  18. Alt DP, Bolin CA, , 1996. Preliminary evaluation of antimicrobial agents for treatment of Leptospira interrogans serovar pomona infection in hamsters and swine. Am J Vet Res 57: 5962.
  19. Alt DP, Zuerner RL, Bolin CA, , 2001. Evaluation of antibiotics for treatment of cattle infected with Leptospira borgpetersenii serovar hardjo. J Am Vet Med Assoc 219: 636639.[Crossref]
  20. Kirby WMM, Regamey C, , 1973. Pharmacokinetics of cefazolin compared with four other cephalosporins. J Infect Dis 128: S341S345.[Crossref]
  21. Clinical and Laboratory Standards Institute, 2008. Performance Standards for Antimicrobial Susceptibility Testing; Eighteenth Informational Supplement. CLSI Document M100-S18. Wayne, PA: Clinical and Laboratory Standards Institute.
  22. Levison ME, Johnson WD, Thornhill TS, Kaye D, , 1969. Clinical and in vitro evaluation of cephalexin. JAMA 209: 13311336.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2011.11-0352
Loading
/content/journals/10.4269/ajtmh.2011.11-0352
Loading

Data & Media loading...

  • Received : 03 Jun 2011
  • Accepted : 24 Jun 2011

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error